Efficacy and safety of ShenSongYangXin Capsule combined with antiarrhythmic drugs for atrial fibrillation: A protocol for systematic review and network meta-analysis

BACKGROUND: Shen-Song-Yang-Xin Capsule (SSYX), a Chinese patent medicine, combined with antiarrhythmic drugs (AADs) in the treatment of atrial fibrillation (AF) has been widely applied in clinical practice, but the results are controversial. This study aims to conduct a network meta-analysis (NMA) b...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Shuqing, Shi, Jingjing, Jia, Qiulei, Shi, Shuai, Yuan, Guozhen, Hu, Yuanhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545279/
https://www.ncbi.nlm.nih.gov/pubmed/32957412
http://dx.doi.org/10.1097/MD.0000000000022367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545279/
https://www.ncbi.nlm.nih.gov/pubmed/32957412
http://dx.doi.org/10.1097/MD.0000000000022367

Ejemplares similares